Clinical trial
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-selection Study of S-600918 in Patients With Refractory Chronic Cough
NCT04110054 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-selection Study of S-600918 in Patients With Refractory Chronic Cough
- Lead sponsor
- Shionogi
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 13, 2020
- Completion date
- December 28, 2020
- Enrollment
- 406 (actual)
- Sites
- 136
Conditions
As the registry lists them; a condition with its own page is linked.